Related Experiment Video
Updated: Jun 10, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Stem cell therapy in chronic ischemic heart dysfunction with and without viability
Pedro L Sánchez1, Ricardo Sanz-Ruiz, M Eugenia Fernández-Santos
1Cardiology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Insights
Assessing myocardial viability is crucial for stem cell therapy in chronic ischemic heart dysfunction. This evaluation helps optimize stem cell types and delivery methods for better treatment outcomes.
Area of Science:
- Cardiology
- Regenerative Medicine
- Biomedical Engineering
Background:
- Clinical trials for stem cell therapy in chronic ischemic heart dysfunction are increasing.
- Varied patient numbers, stem cell sources, and delivery methods lead to inconsistent study results.
Purpose of the Study:
- To analyze the importance of myocardial viability assessment in stem cell transplantation studies.
- To determine if viability assessment can optimize stem cell therapy for chronic ischemic heart dysfunction.
Main Methods:
- Review and analysis of existing clinical trial data on stem cell therapy for heart dysfunction.
- Focus on the role of myocardial viability assessment in interpreting treatment effects.
Main Results:
- Results from clinical trials vary significantly due to methodological differences.
- Myocardial viability assessment may be a key factor in understanding treatment efficacy.
Conclusions:
- Incorporating myocardial viability assessment can refine the evaluation of stem cell therapy.
- This approach could guide the selection of optimal stem cell types and delivery methods for improved patient outcomes.
Abstract:
A growing number of clinical trials are evaluating the effects of stem cell therapy in patients with chronic ischemic heart dysfunction. As most of the clinical trials included a limited and different number of patients, various stem cell sources and several delivery approaches, results vary substantially between these studies. We analyse whether the assessment of myocardial viability may be important when evaluating effects of stem cell transplantation on parameters of left ventricular remodeling. Viability assessment could help to find the best type of stem cell and the best method of cell delivery to be used in chronic ischemic heart dysfunction.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture

